Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
891-903
Author(s):
Valerie Gouaze-Andersson and Myles C. Cabot
Ceramide-Based Therapeutics for the Treatment of Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
911-919
Author(s):
Brian M. Barth, Myles C. Cabot and Mark Kester
Anticipation in Lynch Syndrome: Where We Are Where We Go
Journal:
Current Genomics
Volume:
12
Page:
451-465
Author(s):
Cristina Bozzao, Patrizia Lastella and Alessandro Stella
Aberrant DNA Methylation and Prostate Cancer
Journal:
Current Genomics
Volume:
12
Page:
486-505
Author(s):
Sunipa Majumdar, Eric Buckles, John Estrada and Shahriar Koochekpour
Cytokines as Anti-Angiogenic Agents in Haematological Malignancies
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
997-1004
Author(s):
C. Cocco, E. Ferretti, I. Airoldi and V. Pistoia
Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1005-1024
Author(s):
K. Podar and K. C. Anderson
Antiangiogenesis in Myelodysplastic Syndrome
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1044-1052
Author(s):
A. Aguayo, F. M. Armillas-Canseco and D. Martinez-Banos
Clinical Experience with Antiangiogenic Therapy in Leukemia
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1053-1068
Author(s):
J. Wellbrock and W. Fiedler
Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1069-1081
Author(s):
J. Cheng, J. Xu, J. Duanmu, H. Zhou, C. J. Booth and Z. Hu
EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1082-1097
Author(s):
RONG Biao-xue, CAI Xi-guang, YANG Shuan-ying, LI Wei and MING Zong-juan